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Introduction: Nasopharyngeal carcinoma is one of the most difficult tumors to diagnose correctly at the initial
phase because of the occasional lack of nasal symptoms. The perineural spread of the trigeminal nerve is one of
the most common and important routes in the intracranial paracavernous extension of nasopharyngeal carcinoma,
but visual loss is very rare.
Case presentation: We report the case of a 54-year-old Japanese man with nasopharyngeal carcinoma, who
presented with rapid and severe disturbance of left monocular visual acuity and eye movement with a 10-month
history of ipsilateral otitis media and facial pain. Magnetic resonance imaging revealed a lesion in the left fossa of
Rosenmüller, pterygopalatine fossa, sphenoid and ethmoid sinus, and the left cavernous sinus extending to the
orbital apex through the superior orbital fissure. The histopathological diagnosis was nonkeratinizing
undifferentiated nasopharyngeal carcinoma. Epstein–Barr virus was detected by in situ hybridization. Although
focal radiotherapy induced remarkable tumor shrinkage and relieved ocular motor disturbance and facial pain,
his visual acuity did not improve.
Conclusion: The awareness of cranial nerves in addition to intracranial and orbital apex involvement, as in this case,
is important for appropriate diagnosis and treatment planning of nasopharyngeal carcinoma.
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Nasopharyngeal carcinoma (NPC) is a relatively uncom-
mon cancer with an incidence of 0.29 per 100,000
people per year in Japan [1]. However, there are certain
populations in whom the incidence is considerably
higher, including native and foreign-born Chinese,
Southeast Asians, North Africans, and native people of
the Arctic region [2]. The 2005 classification of the
World Health Organization divides NPC on a patho-
logical basis into three histological subtypes: keratinizing
squamous cell carcinoma; nonkeratinizing carcinoma,
which can be further divided into differentiated and un-
differentiated subtypes; and basaloid squamous cell car-
cinoma. Undifferentiated nonkeratinizing NPC is the
most common type of NPC and is strongly associated* Correspondence: nsakaineurosurg@gmail.com
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unless otherwise stated.with the Epstein–Barr virus (EBV) in practically 100% of
cases. The most common site of origin for NPC is the
lateral wall of the nasopharynx, especially the fossa of
Rosenmüller, followed by the superior posterior wall.
Nearly half of patients complain of nasal symptoms.
Symptoms related to Eustachian tube obstruction, such
as serous otitis media, also commonly occur. Headache
and cranial nerve involvement are features of more ad-
vanced stages. A direct lateral spread of NPC involves
the third division of the trigeminal nerve (V3). The peri-
neural spread of the V3 is one of the most common and
important routes in the intracranial paracavernous ex-
tension of NPC [3], but visual loss is very rare [4-6].
We report here the case of a Japanese man with undif-
ferentiated nonkeratinizing NPC, who presented with
acute visual loss following facial pain and serous otitis
media. We discuss the clinical features and diagnosis of
this rare clinical entity.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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A 54-year-old Japanese man was admitted to our neuro-
surgical department for the investigation and treatment
of acute visual loss of his left eye. He had been treated
for left serous otitis media and left facial pain mimicking
trigeminal neuralgia for 10 months by the otolaryngologist
of a local hospital. Neurological examination on admission
showed left visual acuity of no light perception and left
eye movements disturbed in all directions. Gadolinium-
enhanced, fat-suppressed, T1-weighted magnetic reson-
ance (MR) imaging revealed a lesion in the left fossa of
Rosenmüller, pterygopalatine fossa, sphenoid and ethmoid
sinus, and the left cavernous sinus extending to orbital
apex through the superior orbital fissure (Figure 1). With
a tentative diagnosis of malignant skull base tumor, an
endoscopic tumor biopsy from nasopharyngeal tissue
was performed, but failed because the nasopharyngeal
tissue appeared normal and the tumor could not be iden-
tified. Subsequently, the intraorbital tumor was explored
by performing a left frontotemporal craniotomy with an
anterior clinoidectomy. There was no clear plane be-
tween the tumor and the extraocular muscles; therefore,
an infiltration was suspected. A biopsy of the tumor wasFigure 1 T1-weighted magnetic resonance imaging with gadolinium-
lesion in the fossa of Rosenmüller (A; arrowhead, R; right), the forame
(C; arrowhead) extending to orbital apex through the superior orbitaperformed and an intraoperative diagnosis of a malignant
tumor was obtained. Histopathological findings were
characterized by small round blue cells that were im-
munohistochemically positive for Ep-CAM/Ber-EP4
(epithelial marker) and CD117/c-Kit. Ki-67 positive cells
totaled more than 90%. EBV was detected by EBV-
encoded ribonucleic acid in situ hybridization (EBER-
ISH; Figure 2). Considering the MR imaging appearance,
the clinical course, and the histopathological findings, the
patient was diagnosed with nonkeratinizing undifferenti-
ated NPC, which originally occurred in the fossa of
Rosenmüller and was perineurally invading along the V3
to the cavernous sinus.
He received focal radiotherapy at a dose of 46Gy in 23
fractions, which remarkably reduced the tumor size and
relieved left facial pain, facial palsy, facial hypoesthesia,
ocular motor disturbance, hearing loss, and hypoglossal
palsy. However, his left visual acuity did not improve.
After the radiation therapy, 18F-fluoro-2-deoxy-D-glu-
cose positron emission tomography (FDG-PET) was
negative. Therefore, adjuvant chemotherapy was not
strongly advised and was eventually suspended. How-
ever, cervical lymph node metastases were detected by adiethylenetriaminepentaacetic acid showing a well-enhanced
n ovale (B; arrowhead), and the left cavernous sinus
l fissure (D; arrowhead).
Figure 2 Hematoxylin-eosin staining (A) and immunohistochemical staining for Ep-CAM/Ber-EP4 (B), CD117/c-Kit (C), Epstein–Barr
virus-encoded ribonucleic acid in-situ hybridization (D), and Ki-67 (×400 magnification) (E).
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went cervical lymphadenectomy followed by chemoradi-
ation therapy. Although three cycles of cisplatin were
scheduled, only one cycle could be completed because of
leukopenia. He then received additional radiation therapy
(60Gy/30 fractions/43 days). There was no recurrence 18
months after the initial treatment. However, left temporal
and frontal lobe dural metastasis and lung metastasis
were detected by repeat MR imaging and FDG-PET.
Subsequently, he has received stereotactic radiotherapy
and adjuvant chemotherapy with docetaxel hydrate,
cisplatin, and fluorouracil. At present, 39 months after
the initial treatment, he is still able to perform his daily
activities (Karnofsky Performance Scale 80%).
Discussion
The frequency of cranial nerve paralysis in NPC has a
range of 8.0 to 12.4% [7]; cranial nerve invasion is a
well-known poor prognostic factor in NPC [8-10].
Among the cranial nerves, the trigeminal nerve is most
commonly involved in the extension of NPC. However,
visual loss is very rare as an initial cranial nerve symp-
tom of NPC [4-6]. NPC can also invade the inferior
orbital fissure through the ethmoid or sphenoid sinus, as
well as the orbita through the pterygopalatine fossa [11].
Although the incidence of trigeminal nerve involvement
on MR imaging is high, it is often asymptomatic in NPC
[3]. Su and Lui reported that patients could tolerate
perineural infiltration of the extracranial segment of the
trigeminal nerve by NPC in the early stage of the disease
when the tumor is still confined to beneath the base of
the skull [12].
In the present case, the patient was treated for left ser-
ous otitis media and left facial pain mimicking trigemi-
nal neuralgia for 10 months before the acute visual loss.These symptoms indicate that the tumor originally oc-
curred at the fossa of Rosenmüller, then spread along
the V3 and invaded the cavernous sinus and the intraor-
bita. Although he had serous otitis media and facial pain
10 months before the orbital symptoms, the main appar-
ent cranial nerve paralysis in this case was left optic
nerve paralysis with acute visual loss. Furthermore, there
was no actual evidence of the cancer until the orbital
symptoms occurred. We found only four cases in three
case reports of initial optic nerve presentation of NPC
[4-6], in which all patients presented with a rapid and
progressive disturbance of visual acuity with poor prog-
nosis of visual functions. All four patients had optic
neuropathy (three monocular and one binocular). His-
topathological subtypes of these cases were one kera-
tinizing squamous cell carcinoma, two nonkeratinizing
differentiated carcinoma, and one nonkeratinizing un-
differentiated carcinoma.
Gadolinium-enhanced, fat-suppressed, T1-weighted MR
imaging is very useful in detecting perineural tumor inva-
sion and extracranial lesions [3]. In the present case, the
MR image showing a lesion in the left cavernous sinus
initially puzzled us regarding the primary site of the
tumor. Although the imaging studies should include
whole neck region in endemic areas in such a case, we
initially performed the standard cranial MR imaging. We
retrospectively examined the plain computed tomog-
raphy (CT) scan of his head and neck performed by the
previous physician in the screening process, and noticed
a slight enlargement of the left fossa of Rosenmüller. The
fossa of Rosenmüller should be carefully observed on ini-
tial CT or MR imaging because it is the most common
site of origin for NPC.
In the present case, we performed an endoscopic
tumor biopsy from nasopharyngeal tissue with a
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could not reach the pathologic diagnosis. Although we
subsequently performed open biopsy by craniotomy, a
transnasal endoscopic biopsy could have easily and less
invasively been performed instead of craniotomy [13].
In our patient, EBV was detected by EBER-ISH. The
association of EBV is well established in nonkeratinizing
NPC, particularly the undifferentiated subtype, detected
in virtually all cases irrespective of the geographic origin.
It seems reasonable to assume that EBV infection some-
how contributes to the pathogenesis of nonkeratinizing
NPCs [2]. Recently, cell-free circulating EBV DNA was
detected in plasma and serum from patients with NPC
and was reported as an independent prognostic maker
for NPC. In endemic areas, an elevation of the plasma
EBV DNA is one of the strong indicators of NPC [2,14].
By contrast, in EBV-negative squamous cell NPCs, other
factors such as smoking and/or infection with human
papillomaviruses might be involved in the pathogenesis
[2]. In the present case, CD117/c-Kit was positive. C-Kit
is a transmembrane growth factor receptor for stem cell
factor that is not expressed in normal nasopharyngeal
epithelial cells [15]. C-Kit protein was expressed in one-
third of NPCs, restricted to cases of EBV-positive un-
differentiated or nonkeratinizing carcinoma. Although
patients with c-Kit expression are not significantly better
survivors than those without, the molecular target ther-
apy, imatinib mesylate (Gleevec®), is potentially a new
therapeutic approach in NPCs positive for c-Kit [15].
At present, radiation therapy is the first choice for
NPC, and cisplatin therapy is also thought to be effective
[2,8]. The addition of cisplatin-based induction che-
motherapy to radiation therapy was associated with a
modest but significant decrease in relapse, and contrib-
uted to an improvement in disease-specific survival in
advanced-stage NPC. However, there was no improve-
ment in overall survival [2]. We initially did not admin-
ister chemotherapy to our patient after radiation therapy
because locoregional metastasis was not detected by
FDG-PET. However, cervical lymph node metastases,
lung metastasis, and intracranial dural metastasis were
observed during the follow-up period. Eventually the pa-
tient underwent cervical lymphadenectomy and received
chemoradiation therapy. The initial treatment for the
present case (focal radiation therapy: 46Gy/23 fractions
alone without chemotherapy and neck irradiation) was
inadequate. In radiotherapy, a dose of 65 to 75Gy should
have been given to the primary tumor and 65 to 70Gy to
the involved neck nodes because the distant failure rate
is relatively high [2,7].
Although his left vision has not been recovered, he still
lives independently. This clinical course suggests that we
should have performed early nasal endoscopic biopsy
and initiated adjuvant chemotherapy immediately afterthe initial high-dose radiation therapy, with continuing
administration to control tumor recurrence.
Conclusions
NPC is one of the most easily misdiagnosed tumors be-
cause it does not present with nasal symptoms; rather, the
patient may initially have unspecific signs and symptoms
such as headache, hearing loss, and facial pain. Although
symptoms often appear after intracranial invasion, early
optic nerve involvement is very rare. If NPC is suspected,
a rapid pathological diagnosis and a high-dose radiation
therapy with early adjuvant chemoradiotherapy are es-
sential to ensure prolonged patient survival.
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